Kaya Limited has announced its financial results for the quarter and financial year ended March 31, 2026. The Board approved the standalone and consolidated audited financial results, with the statutory auditors providing an unmodified opinion. Furthermore, the Board approved the extension of loans amounting to Rs. 16.19 Crores each from Directors Mr. Harsh Mariwala and Mr. Rajendra Mariwala for a period of seven years. The company’s revenue from operations for the quarter ended March 31, 2026, was Rs. 55.80 Crores compared to Rs. 60.04 Crores in the previous quarter and Rs. 54.69 Crores in the corresponding quarter of the previous year. The net loss for the period stood at Rs. 27.77 Crores, versus a net loss of Rs. 35.55 Crores in the previous quarter and a net loss of Rs. 6.97 Crores in the corresponding quarter of the previous year.

Kaya Limited, founded by Mr. Harsh Mariwala, is a prominent player in the skin, body, and hair care industry, operating a network of specialized dermatology clinics across India. The company leverages scientifically crafted products and personalized solutions, supported by a team of expert dermatologists and clinic personnel to meet the diverse beauty needs of its consumers.

The company continues to prioritize its strategic expansion initiatives, including the development of new clinics and the enhancement of existing facilities through investments in new technology and service capabilities. Throughout 2025, Kaya Limited remained focused on navigating a competitive healthcare landscape, proactively managing its financial obligations, and securing necessary capital infusion to support its long-term growth and operational sustainability. The company also maintained a commitment to transparency, evidenced by its cooperation with regulatory authorities during compliance-related processes during the year.

For the fiscal year ended March 31, 2026, Kaya Limited reported a consolidated net loss of Rs. 96.17 Crores. The company, which counts Axana Estates LLP among its notable recent investors following a preferential share issuance in 2025, continues to receive financial support from the promoter group. Management remains focused on leveraging its annual operating plan to meet funding requirements and maintain going concern status while monitoring evolving economic factors.